Emerging immunotherapies and targeted therapies take aim at recently identified biomarkers ...

Immunotherapy, targeted treatments, HIPEC, and new delivery options ...

The specifics of endoscopic/surgical resection and perioperative treatment ...

The FDA granted breakthrough status to Cogent's GIST drug combo after a trial showed it cut disease progression or death risk ...

Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted therapies like claudin 18.2-directed therapy. Biomarker testing is essential ...

Fecal microbiota transplants (FMT) can dramatically improve cancer treatment, suggest two groundbreaking studies published in ...

Pancreatic cancer treatment relies on surgery, chemotherapy, and radiation, with surgery for non-metastatic, technically ...

Trastuzumab-based regimens were the primary treatment for older adults with advanced HER2-positive gastric cancer before immunotherapy became standard. The study highlights substantial economic ...

Advanced gastroesophageal adenocarcinoma (GEA) with HER2 positivity has long presented significant treatment challenges, with ...

Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each ...